Height and Weight by among girls aged 5–6 in the ABBY Project.

<p>(Upper) Lowess smoother of height and age for each group compared with the UK 1990 Growth References, (Lower) Lowess smoother of weight and age for each group compared with the UK 1990 Growth References.</p

Lowess smoother of the log of DHEAS by age among all girls Aged 5–16 years.

<p>Triangle shows inflection point where log salivary DHEAS reaches 5.5–6 pg/ml, signifying the clinical threshold for adrenarche.</p

Sample characteristics of ABBY project participants; reported as mean (SD) for continuous variables or number and percent for categorical variables.

†<p>indicates statistical difference between Sylheti and the other group at the p<0.05 cut off.</p><p>Sample characteristics of ABBY project participants; reported as mean (SD) for continuous variables or number and percent for categorical variables.</p

Hazard ratios (95% C I) of adrenarche onset among girls <9.5 years adjusted for height, weight, BMI, and waist circumference.

<p>Hazard ratios (95% C I) of adrenarche onset among girls <9.5 years adjusted for height, weight, BMI, and waist circumference.</p

Salivary DHEAS pg/ml by age groups in Sylheti, first-generation, second-generation and European girls, aged 5-16 years.

†<p>indicates statistical difference between Sylheti and first-generation girls at the p<0.05 cut off.</p><p>Salivary DHEAS pg/ml by age groups in Sylheti, first-generation, second-generation and European girls, aged 5-16 years.</p